These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 475429)

  • 1. Carbamazepine dose-frequency requirement in children.
    Rylance GW; Moreland TA; Butcher GM
    Arch Dis Child; 1979 Jun; 54(6):454-8. PubMed ID: 475429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication.
    Aman MG; Werry JS; Paxton JW; Turbott SH; Stewart AW
    Epilepsia; 1990; 31(1):51-60. PubMed ID: 2303013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva carbamazepine levels in children before and during multiple dosing.
    Moreland TA; Priestman DA; Rylance GW
    Br J Clin Pharmacol; 1982 May; 13(5):647-51. PubMed ID: 7082531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy.
    Bäckman E; Dahlström G; Eeg-Olofsson O; Bertler A
    Pediatr Neurol; 1987; 3(6):327-30. PubMed ID: 3149473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
    Vasudev A; Tripathi KD; Puri V
    Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of carbamazepine in plasma and saliva of man.
    Pynnönen S
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):465-71. PubMed ID: 579557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
    Vasudev A; Tripathi KD; Puri V
    Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fallacious results from measuring salivary carbamazepine concentrations.
    Dickinson RG; Hooper WD; King AR; Eadie MJ
    Ther Drug Monit; 1985; 7(1):41-5. PubMed ID: 3992621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva carbamazepine and phenytoin level monitoring.
    Rylance GW; Moreland TA
    Arch Dis Child; 1981 Aug; 56(8):637-40. PubMed ID: 7271302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum.
    Paxton JW; Donald RA
    Clin Pharmacol Ther; 1980 Nov; 28(5):695-702. PubMed ID: 7438687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on carbamazepine levels, including estimation of 10-11 epoxy-carbamazepine and levels in free plasma and saliva.
    Tomlin PI; McKinlay I; Smith I
    Dev Med Child Neurol; 1986 Dec; 28(6):713-8. PubMed ID: 3817310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine dosing for pediatric seizure disorders: the highs and lows.
    Gilman JT
    DICP; 1991 Oct; 25(10):1109-12. PubMed ID: 1803802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary and serum concentrations, and protein binding of carbamazepine in young epileptic patients.
    Paxton JW
    Methods Find Exp Clin Pharmacol; 1983; 5(6):397-401. PubMed ID: 6621183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of saliva in home monitoring of carbamazepine levels.
    Rosenthal E; Hoffer E; Ben-Aryeh H; Badarni S; Benderly A; Hemli Y
    Epilepsia; 1995 Jan; 36(1):72-4. PubMed ID: 8001513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.
    Kanarkowski R; Rybakowski J; Lehmann W; Matkowski K
    Pol J Pharmacol Pharm; 1991; 43(6):479-85. PubMed ID: 1821043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.